BRAIN Biotech AG Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 1/20/2026)
| Balance Sheet | Total Assets | 66,337,000.00 | ROE | 2.78 % |
| Balance Sheet | Total Equity | 1,841,000.00 | ROA | -17.70 % |
| Cashflow | Capital Expenditures | -1,531,000.00 | P/FCF | -5.54 |
| Cashflow | Free Cash Flow | -10,764,000.00 | – | – |
| Cashflow | Operating Cash Flow | -9,233,000.00 | P/CF | -6.46 |
| Income | Earnings per Share (diluted) | -0.54 | Div. Yield | – |
| Income | Net Income | -11,742,000.00 | P/E | -5.06 |
| Income | Shares Outstanding | 21,847,500.00 | P/B | 32.40 |
| Income | Total Revenue | 49,623,000.00 | P/S | 1.20 |
Ratios calculated on: 10/14/2026
Company Description
B.R.A.I.N. Biotechnology Research and Information Network AG researches, develops, produces, and markets enzymes, biocatalysts, microorganisms, and bioactive natural substances for chemical and consumer goods industries in Germany, the United States, France, and the United Kingdom. It operates through BioScience and BioIndustrial segments. The company identifies and develops bioactive natural compounds, including sugar substitutes and taste modulators, and natural-source substances for product development in the food, animal feed, skincare, cosmetics, and chemical industries, as well as to stabilize paints, lacquers, and other household products; It also identifies and develops optimized enzymes and biocatalysts for the production of food and beverages, and wound care preparations and lubricants, as well as for starch processing of bioethanol production; and microorganisms as the functional biomass for optimized industrial production processes, recycling of climate gas CO2 as an industrial raw material for bioplastics, and extraction of precious and rare earth metals. The company has a strategic partnership with AnalytiCon Discovery GmbH and Roquette to develop natural sweeteners and sweet taste enhancers. B.R.A.I.N. Biotechnology Research and Information Network AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.brain-biotech.de
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more